|
gptkbp:instance_of
|
gptkb:Clinical_Trials
|
|
gptkbp:adverse_events_monitored
|
gptkb:Yes
|
|
gptkbp:advocacy
|
obtained
|
|
gptkbp:affiliated_with
|
multiple universities
|
|
gptkbp:analysis
|
intention-to-treat
|
|
gptkbp:analytics
|
gptkb:SPSS
|
|
gptkbp:business_model
|
gptkb:Yes
|
|
gptkbp:clinical_trial
|
gptkb:Clinical_Trials.gov
gptkb:Yes
|
|
gptkbp:collaborator
|
gptkb:University_of_California
|
|
gptkbp:collection
|
clinical assessments
|
|
gptkbp:committee
|
independent committee
|
|
gptkbp:concluded_on
|
Dulaglutide is effective
|
|
gptkbp:condition
|
gptkb:diabetes
|
|
gptkbp:criteria
|
Pregnant women
Adults aged 18-75
|
|
gptkbp:data_safety_monitoring
|
gptkb:Yes
|
|
gptkbp:duration
|
52 weeks
|
|
gptkbp:follow-up_duration
|
6 months
|
|
gptkbp:funding
|
public and private sources
|
|
gptkbp:future_plans
|
further research needed
|
|
gptkbp:future_prospects
|
recommended
|
|
gptkbp:has_implications_for
|
improved diabetes management
|
|
gptkbp:has_limitations
|
short follow-up period
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
EVOLVE-1
|
|
gptkbp:identifier
|
NCT03412345
|
|
gptkbp:investigates
|
gptkb:Dr._John_Smith
|
|
gptkbp:is_studied_in
|
randomized, double-blind, placebo-controlled
|
|
gptkbp:is_tested_for
|
Phase 3
|
|
gptkbp:location
|
multiple countries
|
|
gptkbp:long-term_follow-up
|
gptkb:Yes
|
|
gptkbp:members
|
placebo group
|
|
gptkbp:outcome
|
efficacy of treatment
|
|
gptkbp:participants
|
Change in Hb A1c
Weight change
|
|
gptkbp:patient_population
|
diverse population
|
|
gptkbp:patient_recruitment_method
|
advertisements and referrals
|
|
gptkbp:prevention
|
gptkb:Dulaglutide
|
|
gptkbp:provides_information_on
|
Available upon request
|
|
gptkbp:publication
|
peer-reviewed
|
|
gptkbp:research
|
interventional
|
|
gptkbp:research_output
|
positive efficacy
|
|
gptkbp:research_team_size
|
20 members
|
|
gptkbp:result
|
2022-01-15
|
|
gptkbp:sampled_in
|
gptkb:Yes
|
|
gptkbp:side_effect
|
mandatory
|
|
gptkbp:sponsor
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:start_date
|
2018-01-01
|
|
gptkbp:student_enrollment
|
approximately 2000 participants
|
|
gptkbp:study_results_dissemination
|
conferences and journals
|
|
gptkbp:vision
|
double-blind
|
|
gptkbp:year
|
2021-12-31
2021-06-30
|
|
gptkbp:bfsParent
|
gptkb:Aimovig
gptkb:Emgality
|
|
gptkbp:bfsLayer
|
5
|